Skip to main content
. Author manuscript; available in PMC: 2017 Jan 19.
Published in final edited form as: Breast Cancer Res Treat. 2016 Jan 19;155(2):375–383. doi: 10.1007/s10549-016-3686-2

Figure 2.

Figure 2

Sensitivity (Se.O) and Specificity (Sp.O) of the two-stage approach and BRCAPRO for (a) CGN+MDA and (b) NWH data. The x-axis has two sets of cutoffs, c1 (first stage) followed by c2 (second stage) below it. For BRCAPRO, only one cutoff (indicated by the second level c2 values) is applicable.